NEW YORK--(BUSINESS WIRE)--InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), today announced that RESPeRATE ®, the world’s first FDA-cleared, ...

The computerized musical device called RESPeRATE helps people breathe slowly and lowers their blood pressure, research shows. The RESPeRATE device sells for about $300. Its manufacturer, InterCure Ltd ...

NEW YORK--(BUSINESS WIRE)--InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), today announced that its RESPeRATE ® hypertension treatment device, ...

Fort Lee, NJ -- October 27, 2005 -- It is estimated that eighty percent of the 10 million Americans suffering from both diabetes and hypertension do not reach goal blood pressure (BP) and are at ...

Fort Lee, NJ -- June 30, 2003 Hard-to-control refractory hypertensives witnessed a significant blood pressure reduction when using a new non-drug treatment device, Resperate®, according to a study ...

The product: RESPeRATE looks like the subject line of a junk e-mail, but it’s actually the name of a medical device designed to lower blood pressure by slowing down breathing. Sold over the Internet ...

A new medical device that can lower a person’s blood pressure without the use of drugs was launched yesterday during a symposium of the Philippine Society of Hypertension (PSH) and the Philippine ...

RESPeRATE is a noninvasive medical device for the treatment of hypertension (high blood pressure). It works by tracking a person’s breathing and guiding them to breathe more slowly. Original Medicare ...

TEL AVIV, Israel, April 26, 2017 /PRNewswire/ -- 2breathe Technologies Ltd. with its wholly owned U.S. subsidiary Resperate Inc. announced, today, the publication of a new peer reviewed original ...

Life is stressful. There are a lot of people out there who have high blood pressure or just can't relax. I have had high blood pressure for some time and have not had much luck in treating it.

2breathe Technologies and its U.S. subsidiary Resperate Inc. have announced the publication of an article evaluating its hypertension treatment device, RESPeRATE. The study looked at 95 patients using ...

NEW YORK, Jan. 24 InterCure, Ltd.(Tel Aviv Stock Exchange: INCR) manufacturer of the RESPeRATE(R) hypertensiontreatment device, clinically-proven to significantly lower blood pressure,today announced ...